Patents by Inventor Li Li Bovet

Li Li Bovet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Metered dose inhaler for beclomethasone dipropionate
    Patent number: 6511653
    Abstract: A metered dose inhaler having part or all of its internal surfaces coated with one or more fluorocarbon polymers, optionally in combination with one or more non-fluorocarbon polymers, for dispensing an inhalation drug formulation comprising beclomethasone dipropionate or a physiologically acceptable solvate thereof, and a fluorocarbon propellant, optionally in combination with one or more other pharmacologically active agents or one or more excipients.
    Type: Grant
    Filed: February 18, 2000
    Date of Patent: January 28, 2003
    Assignee: SmithKline Beecham Corp.
    Inventors: Ignatius Loy Britto, Ian Car Ashurst, Craig Steven Herman, Li Li-Bovet, Michael Thomas Riebe
  • Metered dose inhaler for beclomethasone dipropionate
    Patent number: 6511652
    Abstract: A metered dose inhaler having part or all of its internal surfaces coated with one or more fluorocarbon polymers, optionally in combination with one or more non-fluorocarbon polymers, for dispensing an inhalation drug formulation comprising beclomethasone dipropionate or a physiologically acceptable solvate thereof, and a fluorocarbon propellant, optionally in combination with one or more other pharmacologically active agents or one or more excipients.
    Type: Grant
    Filed: February 18, 2000
    Date of Patent: January 28, 2003
    Assignee: SmithKline Beecham Corp.
    Inventors: Ian C. Ashurst, Ignatius Loy Britto, Craig Steven Herman, Li Li-Bovet, Michael Thomas Riebe
  • Medicaments
    Publication number: 20020176824
    Abstract: This invention relates to aerosol formulations of use for the administration of medicaments by inhalation. More particularly, the invention relates to a pharmaceutical aerosol formulation which comprises particulate salbutamol sulphate having a crystalline form in which the outer layer of the crystals is substantially non-amorphous; and 1,1,1,2-tetrafluoroethane. A method of treating respiratory disorders which comprises administration by inhalation of an effective amount of a pharmaceutical aerosol formulation as defined is also described.
    Type: Application
    Filed: June 27, 2002
    Publication date: November 28, 2002
    Inventors: Michael Thomas Riebe, Sarvajna Kumar Dwivedi, Li Li-Bovet
  • Aerosols containing annealed particulate salbutamol and tetrafluoroethane
    Publication number: 20020176825
    Abstract: This invention relates to aerosol formulations of use for the administration of medicaments by inhalation. More particularly, the invention relates to a pharmaceutical aerosol formulation which comprises particulate salbutamol sulfate having a crystalline form in which the outer layer of the crystals is substantially non-amorphous; and 1,1,1,2-tetrafluoroethane. A method of treating respiratory disorders which comprises administration by inhalation of an effective amount of a pharmaceutical aerosol formulation as defined is also described.
    Type: Application
    Filed: June 28, 2002
    Publication date: November 28, 2002
    Inventors: Michael Thomas Riebe, Sarvajna Kumar Dwivedi, Li Li-Bovet
  • Metered dose inhaler for albuterol
    Patent number: 6131566
    Abstract: A metered dose inhaler having all or part of its internal surfaces coated with one or more fluorocarbon polymers, optimally a blend of one or more fluorocarbon polymers in combination with one or more non-fluorocarbon polymers, for dispensing an inhalation drug formation comprising albuterol or a physiologically acceptable salt thereof and a fluorocarbon propellant, optionally in combination with one or more other pharmacologically active agents or one or more excipients.
    Type: Grant
    Filed: March 31, 1997
    Date of Patent: October 17, 2000
    Assignees: Glaxo Wellcome Inc., Glaxo Group Limited
    Inventors: Ian Carl Ashurst, Craig Steven Herman, Li Li-Bovet, Michael Thomas Riebe
  • Pharmaceutical aerosol formulation comprising a medicament, a propellant and a fluorinated surfactant
    Patent number: 5849265
    Abstract: A pharmaceutical aerosol formulation which comprises particulate medicament, a fluorocarbon of hydrogen-containing chlorofluorocarbon propellant and a surfactant of general formula (I), wherein n is an integer of 1 to 18; m is an integer of 0 to 17; and R.sup.1, R.sup.2 and R.sup.3 are each independently a hydrogen atom or a C.sub.1-4 alkyl group.
    Type: Grant
    Filed: March 27, 1997
    Date of Patent: December 15, 1998
    Assignee: Glaxo Wellcome Inc.
    Inventors: Li Li-Bovet, Keith A. Johnson